Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1970
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1975 3
1977 1
1978 3
1979 4
1980 1
1981 5
1982 3
1983 5
1984 8
1985 4
1986 5
1987 9
1988 19
1989 26
1990 33
1991 29
1992 46
1993 64
1994 73
1995 68
1996 74
1997 82
1998 106
1999 71
2000 123
2001 125
2002 106
2003 160
2004 169
2005 143
2006 145
2007 203
2008 190
2009 162
2010 234
2011 251
2012 214
2013 253
2014 235
2015 249
2016 263
2017 266
2018 255
2019 245
2020 326
2021 347
2022 312
2023 304
2024 329
2025 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

5,807 results

Results by year

Filters applied: . Clear all
Page 1
Overview of breast cancer.
Watkins EJ. Watkins EJ. JAAPA. 2019 Oct;32(10):13-17. doi: 10.1097/01.JAA.0000580524.95733.3d. JAAPA. 2019. PMID: 31513033 Review.
Each year, more than 250,000 women in the United States are diagnosed with invasive breast cancer. Although overall mortality for breast cancer patients has declined, it is still the second most common cause of cancer death in women. This article provides an …
Each year, more than 250,000 women in the United States are diagnosed with invasive breast cancer. Although overall mortality …
Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.
Mouabbi JA, Hassan A, Lim B, Hortobagyi GN, Tripathy D, Layman RM. Mouabbi JA, et al. Breast Cancer Res Treat. 2022 Jun;193(2):253-264. doi: 10.1007/s10549-022-06572-w. Epub 2022 Mar 26. Breast Cancer Res Treat. 2022. PMID: 35347549 Review.
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer after invasive ductal carcinoma (IDC), accounting for 10-15% of all breast cancer cases. ...Historically, studies have combined ILC and IDC, wi
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer after invasive du
Histological type and typing of breast carcinomas and the WHO classification changes over time.
Cserni G. Cserni G. Pathologica. 2020 Mar;112(1):25-41. doi: 10.32074/1591-951X-1-20. Pathologica. 2020. PMID: 32202537 Free PMC article. Review.
The World Health Organization's new classification of breast tumors has just been published. This review aims to examine the morphological categorization of breast carcinomas which is still principally based on histological features and follows the traditions of his …
The World Health Organization's new classification of breast tumors has just been published. This review aims to examine the morpholo …
Invasive lobular carcinoma of the breast: the increasing importance of this special subtype.
McCart Reed AE, Kalinowski L, Simpson PT, Lakhani SR. McCart Reed AE, et al. Breast Cancer Res. 2021 Jan 7;23(1):6. doi: 10.1186/s13058-020-01384-6. Breast Cancer Res. 2021. PMID: 33413533 Free PMC article. Review.
Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types, accounting for up to 15% of all breast cancer cases. ...Since last reviewing the lobular literature (McCart Reed et al., Breast Cancer Res 17:12, 2015), ther
Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types, accounting for up to 15% of all
Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease.
Thomas M, Kelly ED, Abraham J, Kruse M. Thomas M, et al. Semin Oncol. 2019 Apr;46(2):121-132. doi: 10.1053/j.seminoncol.2019.03.002. Epub 2019 Jun 17. Semin Oncol. 2019. PMID: 31239068 Review.
Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer after invasive ductal carcinoma (IDC). Invasive lobular carcinoma has unique clinical, pathologic, and radiographic features which sug
Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer after invasive
Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment.
Delaloge S, Khan SA, Wesseling J, Whelan T. Delaloge S, et al. Lancet. 2024 Jun 22;403(10445):2734-2746. doi: 10.1016/S0140-6736(24)00425-2. Epub 2024 May 9. Lancet. 2024. PMID: 38735296 Review.
Ductal carcinoma in situ (DCIS) accounts for 15-25% of all breast cancer diagnoses. Its prognosis is excellent overall, the main risk being the occurrence of local breast events, as most cases of DCIS do not progress to invasive cancer. Systematic scre …
Ductal carcinoma in situ (DCIS) accounts for 15-25% of all breast cancer diagnoses. Its prognosis is excellent overall, the ma …
Is DCIS Overrated?
Feinberg J, Wetstone R, Greenstein D, Borgen P. Feinberg J, et al. Cancer Treat Res. 2018;173:53-72. doi: 10.1007/978-3-319-70197-4_5. Cancer Treat Res. 2018. PMID: 29349758 Review.
Ductal carcinoma in situ (DCIS), the noninvasive form of breast cancer (BC), comprises just over 20% of breast cancer cases diagnosed each year in the USA. ...Are these strikingly high success rates a testament to effective treatment strategies or is there a …
Ductal carcinoma in situ (DCIS), the noninvasive form of breast cancer (BC), comprises just over 20% of breast cancer c …
A Brief Review on Breast Carcinoma and Deliberation on Current Non Invasive Imaging Techniques for Detection.
Vairavan R, Abdullah O, Retnasamy PB, Sauli Z, Shahimin MM, Retnasamy V. Vairavan R, et al. Curr Med Imaging Rev. 2019;15(2):85-121. doi: 10.2174/1573405613666170912115617. Curr Med Imaging Rev. 2019. PMID: 31975658 Review.
BACKGROUND: Breast carcinoma is a life threatening disease that accounts for 25.1% of all carcinoma among women worldwide. ...CONCLUSION: This paper aims to serve as a foundation guidance for the reader to attain bird's eye understanding on breast c
BACKGROUND: Breast carcinoma is a life threatening disease that accounts for 25.1% of all carcinoma among women worldwi …
Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics.
McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT. McCart Reed AE, et al. Breast Cancer Res. 2015 Jan 30;17(1):12. doi: 10.1186/s13058-015-0519-x. Breast Cancer Res. 2015. PMID: 25849106 Free PMC article. Review.
Invasive lobular carcinoma of the breast is the most common 'special' morphological subtype of breast cancer, comprising up to 15% of all cases. ...Despite this, clinicians face countless challenges in the diagnosis and long-term management of patients
Invasive lobular carcinoma of the breast is the most common 'special' morphological subtype of breast cancer, co
Cancer du sein au stade précoce : stopper la désescalade en radiothérapie.
Cutuli B. Cutuli B. Bull Cancer. 2016 Jun;103(6 Suppl 1):S105-9. doi: 10.1016/S0007-4551(16)30154-0. Bull Cancer. 2016. PMID: 27494965 Review. French.
REFLEXIONS ABOUT NEW STRATEGIES OF RADIOTHERAPY FOR EARLY BREAST CANCER: Radiotherapy (RT) remains a major treatment element in early breast cancer, with a major impact on local control and survival. For ductal carcinoma in situ (DCIS), RT reduces local recur …
REFLEXIONS ABOUT NEW STRATEGIES OF RADIOTHERAPY FOR EARLY BREAST CANCER: Radiotherapy (RT) remains a major treatment element in early …
5,807 results